cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Unang arifin
Contact Email
bcsp@unisba.ac.id
Phone
+6289691247094
Journal Mail Official
bcsp@unisba.ac.id
Editorial Address
UPT Publikasi Ilmiah, Universitas Islam Bandung. Jl. Tamansari No. 20, Bandung 40116, Indonesia, Tlp +62 22 420 3368, +62 22 426 3895 ext. 6891
Location
Kota bandung,
Jawa barat
INDONESIA
Bandung Conference Series: Pharmacy
Published by Universitas Islam Bandung
ISSN : -     EISSN : 28282116     DOI : https://doi.org/10.29313/bcsp.v2i2
Core Subject : Health, Science,
Chemistry Medicine & Pharmacology Public Health
Bandung Conference Series: Pharmacy (BCSP) menerbitkan artikel penelitian akademik tentang kajian teoritis dan terapan serta berfokus pada Farmasi dengan ruang lingkup Airlock system Kanker, Alcohol, Antelmintik, Antigastritis drugs, Antioksidan, Artemia franciscana, Ascaris suum, Cacing babi (Ascaris suum Goeze), Contact Bioautography TLC, Daun cincau hijau (Cyclea barbata Miers), Daun kelor (Moringa oleifera Lam), Diabetes mellitus, DPPH Flavonoid, Fenilpropanolamin, Fermentasi, Flavonoid, Flavonol,Iles-iles, Isolasi, Lichen, Malassezia furfur, Metode Brine Shrimp Lethality Test (BSLT), Obat antidiabetes (OAD) Propionibacterium acnes, Obat tradisional, Parkia Speciosa Antibakteri, Pektin, Propionibacterium Acnes, Pseudoefedrin, Saccharomyces Cerevisiae, Spektrofotometri uv sinar tampak, Staphylococcus epidermidis, uji aktivitas antibakteri, Uji sitotoksik, Usnea baileyi. Prosiding ini diterbitkan oleh UPT Publikasi Ilmiah Unisba. Artikel yang dikirimkan ke prosiding ini akan diproses secara online dan menggunakan double blind review minimal oleh dua orang mitra bebestari.
Arjuna Subject : Pharmacology, Toxicology and Pharmaceutics - Ilmu Farmasi
Articles 1 Documents
 1 
Search results for , issue "807 - 816" : 1 Documents clear
Profil Regimen Kemoterapi pada Pasien Kanker Paru Stadium III Di RS X Periode 2023-2025 Adelia Nanda Maulana; Suwendar Suwendar; Bambang Tri Laksono
Bandung Conference Series: Pharmacy 807 - 816
Publisher : UNISBA Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29313/bcsp.v6i2.25747

Abstract

Abstract. The prescription of chemotherapy (cytostatic drugs) as the primary treatment for lung cancer must be carried out with caution and under close supervision. This study aims to determine the rationale for regimen profile of chemotherapy to stage III lung cancer patients at X Hospital during the 2023–2025 period. The study was conducted as a descriptive observational study using a retrospective approach based on medical records of stage III lung cancer patients in the Inpatient Ward. . A total of 99 patients met the study criteria, with Non-Small Cell Lung Cancer (NSCLC) being the predominant type (92.9%). The Carboplatin–Paclitaxel regimen (45.5%) was found to be the most commonly used for NSCLC, while for Small Cell Lung Cancer (SCLC), it was the Etoposide–Carboplatin regimen (5.2%). The most commonly used supportive therapies included antiemetics, gastroprotectants, intravenous fluids and electrolytes, analgesics, corticosteroids, and bronchodilators. Abstrak. Peresepan kemoterapi (sitostatika) sebagai modalitas utama kanker paru harus dilakukan dengan kehati-hatian dan pengawasan ketat. Penelitian ini bertujuan untuk mengetahui profil regimen kemoterapi pada pasien kanker paru stadium III di Instalasi Rawat Inap RS X periode 2023–2025. Penelitian  dilakukan secara observasional deskriptif dengan pendekatan retrospektif berdasarkan data rekam medis pasien kanker paru stadium III di Instalasi Rawat Inap. Sebanyak 99 pasien memenuhi kriteria penelitian, dengan dominasi Non-Small Cell Lung Cancer (NSCLC) (92,9%). Ditemukan Regimen kemoterapi Carboplatin - Paklitaksel (45,5%) paling banyak digunakan pada NSCLC, sedangkan pada Small Cell Lung Cancer (SCLC) adalah Etoposid Carboplatin (5,2%).. Terapi suportif yang paling banyak digunakan antara lain golongan antiemetik, gastroprotektor, cairan infus dan elektorlit, analgesik, koritkosteroid, serta bronkodilator

Page 1 of 1 | Total Record : 1

 1 

Filter by Year

0000


Reset
Filter By Issues
All Issue Vol. 6 No. 1 (2026): Bandung Conference Series: Pharmacy Vol. 5 No. 2 (2025): Bandung Conference Series: Pharmacy Vol. 4 No. 2 (2024): Bandung Conference Series: Pharmacy Vol. 4 No. 1 (2024): Bandung Conference Series: Pharmacy Vol. 3 No. 2 (2023): Bandung Conference Series: Pharmacy Vol. 3 No. 1 (2023): Bandung Conference Series: Pharmacy Vol. 2 No. 2 (2022): Bandung Conference Series: Pharmacy Vol. 2 No. 1 (2022): Bandung Conference Series: Pharmacy Vol. 1 No. 1 (2021): Bandung Conference Series: Pharmacy 975 - 984 967 - 974 959 - 966 949 - 958 941 - 948 933 - 940 923 - 932 913 - 922 905 - 912 897 - 904 887 - 896 877 - 886 869 - 876 861 - 868 853 - 860 843 - 852 835 - 842 827 - 834 817 - 826 807 - 816 799 - 806 789 - 798 779 - 788 771 - 778 763 - 770 753 - 762 745 - 752 737 - 744 727 - 736 717 - 726 709 - 716 701 - 708 693 - 700 685 - 692 675 - 684 663 - 674 655 - 662 645 - 654 637 - 644 629 - 636 621 - 628 611 - 620 603 - 610 595 - 602 587 - 594 579 - 586 571 - 578 561 - 570 553 - 560 543 - 552 535 - 542 527 - 534 517 - 526 509 - 516 501 - 508 491 - 500 483 - 490 475 - 482 467 - 474 459 - 466 449 - 458 441 - 448 433 - 440 423 - 432 415 - 422 407 - 414 399 - 406 391 - 398 383 - 390 375 - 382 365 - 374 355 - 364 347 - 354 339 - 346 331 - 338 321 - 330 311 - 320 303 - 310 295 - 302 285 - 294 275 - 284 265 - 274 255 - 264 247 - 254 237 - 246 227 - 236 217 - 226 209 - 216 201 - 208 191 - 200 183 - 190 171 - 182 163 - 170 155 - 162 147 - 154 139 - 146 129 - 138 121 - 128 113 - 120 105 - 112 95 - 104 87 - 94 79 - 86 67 - 78 59 - 66 51 - 58 43 - 50 33 - 42 More Issue